These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


168 related items for PubMed ID: 15279389

  • 1. [Anti HLA post-transplant antibodies. A new method of monitorization].
    López-Hoyos M, Fernández-Fresnedo G, Pastor JM, Arias M.
    Nefrologia; 2004; 24 Suppl 4():62-6. PubMed ID: 15279389
    [No Abstract] [Full Text] [Related]

  • 2. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC, Ozawa M.
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [Abstract] [Full Text] [Related]

  • 3. Effect of anti-HLA and anti-idiotypic antibodies on the long-term survival of heart and kidney allografts.
    Reed E, Cohen DJ, Barr ML, Ho E, Marboe CC, Rose EA, Hardy M, Suciu-Foca N.
    Transplant Proc; 1992 Dec; 24(6):2494-5. PubMed ID: 1465842
    [Abstract] [Full Text] [Related]

  • 4. Autoreactive IgM non-HLA antibodies are not entirely clinically irrelevant. The Manchester UK Kidney Transplant Team.
    Martin S, Dyer PA, Scott PD.
    Transplant Proc; 1992 Dec; 24(6):2504. PubMed ID: 1465846
    [No Abstract] [Full Text] [Related]

  • 5. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss.
    Panigrahi A, Gupta N, Siddiqui JA, Margoob A, Bhowmik D, Guleria S, Mehra NK.
    Hum Immunol; 2007 May; 68(5):362-7. PubMed ID: 17462503
    [Abstract] [Full Text] [Related]

  • 6. Presence of IgG HLA antibodies in patients with long-surviving renal allografts.
    Norman PJ, Harmer AW, Koffman CG, Vaughan RW.
    Transplant Proc; 1995 Feb; 27(1):999-1000. PubMed ID: 7879260
    [No Abstract] [Full Text] [Related]

  • 7. Disappearance of anti-HLA antibodies in highly sensitized patients treated with erythropoietin.
    Mourad G, Cristol JP, Chong G, Lorho R, Argiles A, Seignalet J, Mion C.
    Transplant Proc; 1992 Dec; 24(6):2512-3. PubMed ID: 1465849
    [No Abstract] [Full Text] [Related]

  • 8. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL, Jin XB, Li XT, Wang HW, Lü JJ.
    Chin Med J (Engl); 2009 Feb 20; 122(4):420-6. PubMed ID: 19302748
    [Abstract] [Full Text] [Related]

  • 9. Abrogation of anti-HLA antibodies via proteasome inhibition.
    Trivedi HL, Terasaki PI, Feroz A, Everly MJ, Vanikar AV, Shankar V, Trivedi VB, Kaneku H, Idica AK, Modi PR, Khemchandani SI, Dave SD.
    Transplantation; 2009 May 27; 87(10):1555-61. PubMed ID: 19461494
    [Abstract] [Full Text] [Related]

  • 10. Poor graft outcome in recipients with de novo donor-specific anti-HLA antibodies after living related kidney transplantation.
    Li X, Ishida H, Yamaguchi Y, Tanabe K.
    Transpl Int; 2008 Dec 27; 21(12):1145-52. PubMed ID: 18803618
    [Abstract] [Full Text] [Related]

  • 11. The association among C4d staining in renal transplant biopsies, the production of donor-specific HLA antibodies, and graft outcome.
    Howie AJ.
    Transplantation; 2007 Feb 27; 83(4):373-4. PubMed ID: 17318067
    [No Abstract] [Full Text] [Related]

  • 12. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development.
    Rebellato LM, Ozawa M, Verbanac KM, Catrou P, Haisch CE, Terasaki PI.
    Clin Transpl; 2006 Feb 27; ():241-53. PubMed ID: 18365382
    [Abstract] [Full Text] [Related]

  • 13. Detection of anti-HLA antibodies by solid-phase assay in kidney transplantation: friend or foe?
    Ferrari-Lacraz S, Tiercy JM, Villard J.
    Tissue Antigens; 2012 May 27; 79(5):315-25. PubMed ID: 22489941
    [Abstract] [Full Text] [Related]

  • 14. Clinical relevance of anti-HLA antibodies detected by flow-cytometry bead-based assays--single-center experience.
    Mihaylova A, Baltadjieva D, Boneva P, Ivanova M, Penkova K, Marinova D, Mihailova S, Paskalev E, Simeonov P, Naumova E.
    Hum Immunol; 2006 Oct 27; 67(10):787-94. PubMed ID: 17055355
    [Abstract] [Full Text] [Related]

  • 15. Specific HLA antibody production following renal transplantation.
    Martin S, Dyer PA, Gokal R, Mallick NP, Johnson RW.
    Transplant Proc; 1987 Feb 27; 19(1 Pt 1):898. PubMed ID: 3274885
    [No Abstract] [Full Text] [Related]

  • 16. Summary of the effect of de novo HLA antibodies on chronic kidney graft failure.
    Terasaki P, Lachmann N, Cai J.
    Clin Transpl; 2006 Feb 27; ():455-62. PubMed ID: 18365403
    [Abstract] [Full Text] [Related]

  • 17. Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation.
    Hourmant M, Cesbron-Gautier A, Terasaki PI, Mizutani K, Moreau A, Meurette A, Dantal J, Giral M, Blancho G, Cantarovich D, Karam G, Follea G, Soulillou JP, Bignon JD.
    J Am Soc Nephrol; 2005 Sep 27; 16(9):2804-12. PubMed ID: 16014742
    [Abstract] [Full Text] [Related]

  • 18. Anti-HLA antibodies in kidney transplanted patients.
    Maccarone D, Cervelli C, Parzanese I, Pisani F, Caniglia L, Rascente M, Battistoni C, Famulari A, Adorno D.
    Transplant Proc; 2005 Sep 27; 37(6):2459-60. PubMed ID: 16182708
    [Abstract] [Full Text] [Related]

  • 19. Allosensitization to HLA and MICA is an important measure of renal graft outcome.
    Panigrahi A, Siddiqui JA, Rai A, Margoob A, Khaira A, Bhowmik D, Tiwari SC, Guleria S, Mehra NK.
    Clin Transpl; 2007 Sep 27; ():211-7. PubMed ID: 18637472
    [Abstract] [Full Text] [Related]

  • 20. Role of anti-idiotypic antibodies in sensitized patients awaiting renal transplantation.
    Ramounau-Pigot A, Mourad G, Cristol JP, Argiles A, Seignalet J.
    Transplant Proc; 1992 Dec 27; 24(6):2496. PubMed ID: 1465843
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.